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Slug (Snai2), a member of the Snail family of zinc
finger transcription factors, plays a role in the epithe-
lial-to-mesenchymal transformation (EMT) that oc-
curs during melanocyte emigration from the neural
crest. A role for Slug in the EMT-like loss of cell adhe-
sion and increased cell motility exhibited during mel-
anoma progression has also been proposed. Our im-
munohistochemical studies of melanoma arrays,
however, revealed that Slug expression was actually
higher in nevi than in primary or metastatic melano-
mas. Moreover, Slug expression in melanomas was
not associated with decreased expression of E-cad-
herin, the canonical Slug target in EMT. Comparisons
of endogenous Slug and E-cadherin expression in cul-
tured normal human melanocytes and melanoma cell
lines supported our immunohistochemical findings.
Expression of exogenous Slug in melanocytes and
melanoma cells in vitro, however, suppressed E-cad-
herin expression, enhanced N-cadherin expression,
and stimulated cell migration and invasion. Interest-
ingly, both in tumors and cultured cell lines, there
was a clear relationship between expression of Slug
and MITF, a transcription factor known to regulate
Slug expression during development. Taken together,
our findings suggest that Slug expression during
melanomagenesis is highest early in the process and
that persistent Slug expression is not required for
melanoma progression. The precise role of Slug in
melanomagenesis remains to be elucidated and may
be related to its interactions with other drivers of
EMT, such as Snail. (Am J Pathol 2012, 180:2479–2489;
http://dx.doi.org/10.1016/j.ajpath.2012.02.014)Snail (Snai1) and Slug (Snai2), evolutionarily conserved
members of the Snail family of zinc finger transcription
factors, play an important role in embryonic develop-
ment.1–4 They regulate the process of epithelial-mesen-
chymal transformation (EMT), characterized by loss of
intercellular adhesions and acquisition of a migratory
phenotype.5,6 EMT is essential for a variety of develop-
mental processes in vertebrates, including mesoderm
formation during gastrulation and neural crest cell migra-
tion.7 Slug is expressed in both premigratory and migra-
tory neural crest cells in the chick, but only in migratory
neural crest cells in the mouse. Conversely, Snail is ex-
pressed only in migratory neural crest cells in the chick,
but in both premigratory and migratory cell populations in
the mouse. These findings suggest that the site and tim-
ing of expression of the two Snail family members have
been exchanged in the avian compared to the mamma-
lian lineage. Overexpressing Slug and Snail in the chick
embryo hindbrain demonstrates that Slug and Snail drive
very similar events in neural crest formation, despite
these differences in expression patterns.8
Snail appears to be essential for normal mesoderm
formation in many species, and Snail knockout mice die
early during gestation.9–11 Treatment of the chick embryo
with Slug antisense oligonucleotides impairs both meso-
derm and neural crest delamination, thus Slug is essen-
tial for normal embryogenesis in this species.9 Slug
knockout mice, on the other hand, are viable and un-
dergo relatively normal gastrulation and neural crest cell
differentiation, although it appears that melanocyte mi-
gration and maturation are compromised in the absence
of Slug.1,12 Slug knockout mice exhibit hypopigmentation
at their extremities and on their heads reminiscent of
Waardenberg syndrome in humans, a condition charac-
terized by the absence of melanocytes leading to hetero-
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In humans, deletions of Slug have been associated with
Waardenberg syndrome.14 Mutations in the MITF, endo-
thelin 3, or its receptor EDNRB genes also produce
Waardenberg syndrome.15,16 Slug has been shown to be
a target of MITF regulation in Xenopus, and Slug may also
reciprocally regulate MITF in this species.17 Piebaldism,
a heritable human condition characterized by patchy de-
pigmented areas of skin is usually due to KIT gene mu-
tations, but it has also been linked to Slug deletion.18
Studies in mice have shown that Slug is a downstream
target of Kit activation.12 A further link between Slug and
melanocytes is provided by the observation that overex-
pression of Slug in Xenopus embryos results in increased
numbers of melanocytes.19
The Snail family also appears to play a role in melano-
cyte transformation. Slug and Snail are expressed at high
levels in a variety of tumor types, including melanoma. In
melanoma cells in vitro, Slug and Snail drive EMT-like
processes that would be expected to enhance tumor
progression, invasion, and metastasis in vivo.20–23 Ex-
pression of Snail has been reported to be elevated in
melanoma cells compared to untransformed melano-
cytes.24,25 In melanoma cells, expression of Snail is as-
sociated with loss of cell-cell adhesion mediated by E-
cadherin, increased motility, and enhanced expression of
proteases.24–28 Slug is reportedly expressed at compa-
rable levels in melanocytes and in melanoma cells in vitro,
although the expression of Slug is essential for metasta-
sis of murine melanoma allografts in nude mice.23,29
Moreover, expression of Slug also increases resistance of
human melanoma cells to chemotherapeutic drugs.22,30 It
has been suggested that the role of Slug in melanocyte
migration during development predisposes melanomas to
metastasize via a Slug-dependent mechanism.29
In the present studies, we examined the expression of
Slug protein by immunohistochemistry in nevi, primary
melanomas, and metastatic melanomas. Slug expression
was significantly higher in nevi compared to primary and
metastatic melanomas. Expression of Slug was not cor-
related with loss of protein expression of its best known
target gene E-cadherin, but was positively associated
with protein expression of MITF, a known upstream reg-
ulator of Slug expression. In vitro studies showed that
Slug mRNA and protein expression was higher in primary
melanocytes than in melanoma cell lines. These findings
suggest that Slug expression during melanomagenesis is
highest early during the process and that persistent Slug
expression is not required for the maintenance of invasive
or metastatic behavior in melanomas.
Materials and Methods
Tissue Samples
A commercial tissue array (commercial array) consisting
of triplicate samples of 30 cases of primary melanoma
(10 acral, 17 nonacral, 1 mucosal, and 2 from unspecified
sites) and 30 cases of metastatic melanoma was pur-
chased (ME207) (US Biomax, Rockville, MD). A second,previously described, custom melanocytic tumor pro-
gression array (custom array) was composed of 36 nevi,
57 primary melanomas, and 75 melanoma metastases
(two to six tissue cores per case).31 This array was pre-
pared as a collaboration of Skin SPOREs sponsored by
the Organ Systems Branch of the National Cancer Insti-
tute. Tumor samples consisting of melanomas with resid-
ual nevus cells were obtained from the Tissue Resource
and Pathology Core (Melanoma Tumor Bank) of the MD
Anderson Melanoma Specialized Program of Research
Excellence (SPORE) project. This study was approved by
the University of Texas MD Anderson Cancer Center In-
stitutional Review Board (protocol no. LAB11-0081) and
was conducted according to the Health Insurance and
Portability and Accountability Act guidelines. A written
informed consent was obtained from all subjects.
Immunohistochemistry
Both arrays were stained for Slug (#9585; Cell Signal-
ing Technology, Danvers, MA), E-cadherin (#4065; Cell
Signaling Technology), and MITF (D5) (Thermo Fisher
Scientific, Rockford, IL). For Slug and E-cadherin immu-
nohistochemistry, slides were deparaffinized and rehy-
drated, endogenous peroxidase activity was blocked
with 3% H2O2 in water, antigen retrieval was performed in
10 mmol/L citrate buffer, and nonspecific binding was
blocked with Biocare Blocking Reagent (Concord, CA).
Slug antibody was applied at a dilution of 1:50 for an
overnight incubation at 4°C, followed by 30-minutes in-
cubation at room temperature with Biocare Rabbit on
Rodent HRP-Polymer. E-cadherin antibody was diluted
1:50 and applied for 1 hour at room temperature; Envision
Plus labeled anti-rabbit HRP polymer (Dako, Carpinteria,
CA) was then applied for 30 minutes at room tempera-
ture. The chromagen used was 3,3=-diaminobenzidine.
Immunohistochemistry for MITF on the commercial array
was performed at a primary antibody dilution of 1:40. The
Bond polymer detection system and an automated stainer
(LeicaMicrosystems, Newcastle upon Tyne, UK) were used
to detect immunohistochemical reactivity, following the
manufacturer’s guidelines. Immunohistochemistry for MITF
on the custom array was performed as previously de-
scribed.31
Scoring
Each tissue array was examined by two pathologists: one
American Board of Pathology certified physician (VG, LD,
or CTC) and one American College of Veterinary Pathol-
ogy certified veterinary pathologist (DK). All cases
stained by single immunohistochemical stain were eval-
uated by a single primary pathologist; scores assigned
by the primary examiner were verified by a second pa-
thologist and a single final score was obtained for each
tumor. Tissues were scored on a scale of 0 to 3 based on
the combined extent and intensity of staining. The final
score for a case represented the predominant staining
pattern in all tissue cores for that case. E-cadherin stain-
ing intensity was based on total E-cadherin staining, in-
cluding both cytoplasmic and membrane localized stain-
Slug and Melanomagenesis 2481
AJP June 2012, Vol. 180, No. 6ing. In addition, the predominant pattern of E-cadherin
staining, whether localized to cell membranes or intracy-
toplasmic, was determined for each tumor scored as
E-cadherin positive.
Cell Culture, Adenoviral Transduction, and
Immunofluorescence
Normal human melanocytes (NHM) of neonatal origin
were obtained from the ATCC (Manassas, VA) and were
maintained in Dermal Basal Medium supplemented with
a melanocyte growth kit (ATCC). Melanoma cell lines
(WC62 and WM115) were obtained from the Coriell Insti-
tute (Camden, NJ) and maintained in Eagle’s Modified
Essential Medium (ATCC) supplemented with 10% nor-
mal calf serum (Thermo Scientific, Hudson, NJ). Cells
were grown to 75% confluence then incubated with a
Slug-expressing adenovirus Slug (Ad-Slug) or a control
adenovirus (Ad-Null from Vector Biolabs, Philadelphia,
PA).32 For transduction, 10 l of adenoviral stock (viral
titer 108 ifu/mL) mixed with 1 mL of medium was added to
each well of a 6-well plate. Cells were incubated with the
adenovirus for 24 hours before the medium was
changed. After cell harvest, mRNA was isolated using the
RNeasy kit (Qiagen, Valencia, CA) and protein was iso-
lated using radioimmunoprecipitation assay buffer sup-
plemented with Halt protease inhibitor cocktail (Thermo
Scientific). For immunofluorescence studies, NHM trans-
duced with Ad-Null or Ad-Slug were grown in chamber
slides, fixed briefly with neutral buffered formalin, and
thoroughly rinsed with PBS. After blocking for an hour
with 5% normal goat serum and 0.3% Triton X-100 in PBS,
E-cadherin antibody (#4065) (Cell Signaling Technology)
diluted 1:200 in 1% bovine serum albumin and 0.3%
Triton X-100 in PBS was applied for overnight incubation
at 4°C. The next day, cells were rinsed and secondary
antibody (goat anti-rabbit IgG) (HL), F(ab=)2 fragment,
Alexa Fluor 488 Conjugate (#4412; Cell Signaling Technol-
ogy) diluted 1:1000 in 1% bovine serum albumin and 0.3%
Triton X-100 in PBS was applied for an hour. Slides were
rinsed and coverslipped using Vectashield mounting me-
dium (Vector Laboratories, Burlingame, CA). All incubations
were performed in the dark.
Western Blot
Whole cell lysates in RIPA buffer plus Halt protease in-
hibitor cocktail (Thermo Scientific) were cleared by cen-
trifuging at 10,000 rpm for 10 minutes at 4°C. Forty g of
protein was loaded on 4% to 20% Tris-HCL gel (BioRad,
Hercules, CA). Following SDS-PAGE, protein was trans-
ferred to polyvinylidene difluoride membrane (Sigma-Al-
drich, St. Louis, MO) and probed for Slug (#9585; Cell
Signaling Technology), Snail (#3895; Cell Signaling Tech-
nology), E-cadherin (#4065; Cell Signaling Technology),
N-cadherin (antibody 610920; BD Biosciences, San
Jose, CA), MITF (ab73930; Abcam, Cambridge, MA), or
GAPDH (ab9485; Abcam). The secondary antibody used
for Slug, E-cadherin, MITF, and GAPDH detection was
anti-rabbit IgG horseradish peroxidase (NA934V; GEHealthcare Life Sciences, Piscataway, NJ). The second-
ary antibody used for N-cadherin and Snail was anti-
mouse IgG horseradish peroxidase (#7076; Cell Signal-
ing Technology). Primary antibodies were used at 1:1000
dilutions, whereas secondary antibody concentrations dilu-
tions were 1:5000. Blots were incubated overnight at 4°C
with primary antibody and 2 hours at room temperature
with secondary antibodies. Membranes were incubated
in Super Signal West ECL (Thermo Fisher Scientific) and
then exposed to film.
Quantitative RT-qPCR
For mRNA analysis, RNA was isolated using the RNeasy
kit from Qiagen and cDNA was generated using the High
Capacity cDNA RT kit from Applied Biosystems (Foster
City, CA). Following reverse transcription, qPCR was per-
formed using TaqMan gene expression assays for Snai1
(Hs00195591), Snai2 (Hs00950344), Cdh1 (E-cadherin;
Hs01023814), Cdh2 (N-cadherin; Hs00362037), and
RN18S1 (18S; Hs03928990) together with TaqMan Uni-
versal Master Mix (4304437; Applied Biosystems). Am-
plifications were performed on a 7900HT Real-Time PCR
Analyzer (Applied Biosystems) using the standard curve
method for quantitation.33
Proliferation Assays
Cells were seeded in 96 well dishes and transduced with
Ad-Slug or Ad-Null 24 hours after plating. On successive
days, 3-[4,5-dimethylthiazol-2-yl]2,5-diphenyl tetrazo-
lium bromide (MTT) (Sigma-Aldrich) was added and cells
were incubated for 3 hours. MTT crystals were dissolved
in MTT solvent (0.1 N HCl in anhydrous isopropanol) and
absorbance was measured at 570 nm. Concurrently, cell
numbers were counted manually by the Trypan Blue ex-
clusion method.
Migration Assays
NHM were transduced with Ad-Slug or Ad-Null and
plated into uncoated or Matrigel-coated (Becton, Dickin-
son and Company Biosystems, Bedford, MA) transwell
chambers containing complete medium 48 hours later.
After 24 hours, upper chambers were cleaned of remaining
cells and membranes were fixed and stained to visualize
migrating cells (DiffQuick Kit, Sigma-Aldrich). Dye was ex-
tracted from transwell membranes using methanol and ab-
sorbance measured with a spectrophotometer at 550 nm.
For cell migration assays, cells were transduced with Ad-
Slug or Ad-Null; 24 hours after infection, a linear defect was
generated in cell monolayers using a 10 L pipette tip.
Images were captured on days 0, 1 and 3 to monitor cell
migration. All migration assays were conducted in the pres-
ence of 10 mg/mL mitomycin C (Sigma-Aldrich) to block
proliferation.
Statistical Analysis
For statistical comparison of tumor immunohistochemis-
try, cases were classified as negative (scores of 0 or 1) or
tatic me
ociation
2482 Shirley et al
AJP June 2012, Vol. 180, No. 6positive (scores of 2 or 3). Pairwise associations between
positive staining and tumor stage and between positive
staining for different markers were determined by Fisher’s
exact test. Values for RT-qPCR and migration and invasion
assays are the average of two to three independent studies,
each performed in triplicate; groups were compared using
Student’s t-test. Oncomine (Compendia Bioscience, Ann
Arbor, MI) was used for analysis of previously published
and publically available RNA microarray studies.
Results
Progression-Related Slug Expression in
Melanocytic Tumors
As shown in Figure 1A, approximately 50% of all mela-
nomas in the commercial array were Slug positive. There
was no difference between acral and nonacral melano-
mas or between primary and metastatic melanomas. This
commercial array contained a fairly small number of
nonacral melanomas and no samples of nevi, and there-
fore we examined a more comprehensive custom array.
When this custom array was examined, there was a clear
difference in Slug expression in nevi, primary melano-
mas, and metastatic melanomas. Sixty-seven percent of
nevi were Slug positive, compared to 47% of primary
cutaneous melanomas and 17% of metastatic melano-
mas (Figure 1B). Differences in Slug protein expression
between nevi and metastatic melanomas (P  0.0001)
Figure 1. Immunohistochemistry demonstrates that expression of Slug, E-cadh
differences were not found in expression of Slug, E-cadherin, and MITF in prim
evaluated. B: In a custom array, there were significant differences among ne
E-cadherin, and MITF protein. For both tissue arrays, immunohistochemistry w
or3 staining), and results were compared in a pairwise fashion by Fisher’s exa
primary melanoma). C: E-cadherin protein localization was evaluated in the cust
The percentage of E-cadherin-positive tumors with predominantly membrane E
E-cadherin-positive tumors that were also Slug positive was lowest in metas
localization of E-cadherin decreased with tumor progression. None of these assand between primary and metastatic melanomas (P 0.0002) were highly significant, and the difference be-
tween nevi and primary melanomas (P  0.0534) ap-
proached significance. In this regard, it is important to
note that immunostaining for Slug in the present studies
was performed using a highly specific antibody, whereas
previous studies often used less specific antibodies that
give spurious cytoplasmic staining.20,34
To further investigate the relationship between Slug
protein expression in nevi versus primary melanomas,
expression of Slug was compared in four different mela-
nomas that arose within nevi. For these tumors, slides
were available that included both melanoma and residual
nevus cells, allowing direct comparison of Slug staining
in the two cell populations. In three of these tumors, Slug
staining was clearly more intense in nevus cells com-
pared to melanoma cells (Figure 2); in one of the four
tumors, melanoma cells stained more strongly for Slug
than residual nevus cells. These findings suggest that
Slug protein expression in nevi is often lost or reduced as
the nevi undergo malignant transformation.
Expression of Slug-Related Genes in
Melanocytic Tumors
E-cadherin (Cdh1) is perhaps the best studied Slug tar-
get gene. Slug directly represses the E-cadherin pro-
moter in a variety of cell types and elevated Slug expres-
sion has been linked to decreased E-cadherin
expression and tumor progression in several tumor
MITF protein in melanomas is altered during tumor progression. A: Significant
al, primary nonacral, and metastatic melanomas when a commercial array was
ary cutaneous melanomas, and metastatic melanomas in expression of Slug,
rmed, and tumors were scored as negative (0 or  1 staining) or positive (2
 0.05 for difference from metastatic melanoma; †P 0.05 for difference from
. The percentage of all tumors that were E-cadherin positive was lowest in nevi.
n localization decreased as a function of tumor progression. The percentage of
lanomas. In tumors that were both Slug and E-cadherin positive, membrane
s was statistically significant.erin, and
ary acr
vi, prim
as perfo
ct test *P
om array
-cadheritypes.6,35–41 Moreover, loss of E-cadherin is a critical
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of tumors expressed E-cadherin protein (Figure 1A), and
there was no difference in E-cadherin expression among
the different tumor types. Moreover, there was no signif-
icant association between Slug and E-cadherin protein
expression in any tumor type. In the custom array, there
were significantly fewer E-cadherin expressing nevi than
primary (P  0.0001) or metastatic melanomas (P 
0.0002), but there was no difference between primary
and metastatic melanomas (Figure 1B). Surprisingly,
there was no significant association between Slug and
E-cadherin protein expression at any stage of tumor pro-
gression, in either the commercial or custom array.
Localization of E-cadherin in E-cadherin-positive tu-
mors was also evaluated (Figure 1C). The number of
melanomas that could be evaluated in the commercial
array was too small to permit analysis; however, when the
larger custom array was examined, clear trends of E-
cadherin localization emerged. The proportion of tumors,
with cytoplasmic as opposed to membrane localization of
E-cadherin, increased with tumor stage from 18% in nevi
to 55% in primary melanomas and 68% in metastatic
melanomas. This was consistent with previous reports
that loss of membrane-bound E-cadherin is associated
with invasiveness in melanomas.43 Among the E-cad-
herin-positive tumors, approximately 50% of nevi and
primary melanomas were Slug positive, but only 20% of
metastatic melanomas were Slug positive, suggesting
that co-expression of E-cadherin and Slug protein was
lost as tumors progressed. In addition, the proportion of
Slug-positive tumors with cytoplasmic E-cadherin local-
ization increased dramatically with tumor progression
from 0% in nevi to 50% in primary melanomas to 85% in
metastatic melanomas. This was consistent with previous
reports of Slug-dependent E-cadherin internalization in
other cell types.44,45 These associations between Slug
expression and E-cadherin localization, although sug-
gestive, were not statistically significant. Taken together,
our results indicated that there was no simple relationship
between Slug protein expression and E-cadherin protein
Figure 2. In most melanomas with residual nevus cells, Slug immunoreac-
tivity is strongest in nevus cells. A: In this H&E-stained section of cutaneous
melanoma, both melanoma (M) and nevus (N) cells can be identified. B:
Immunohistochemical staining of an adjacent section of the same tumor
shows stronger Slug immunoreactivity in nevus than in melanoma cells. The
small lymphocytes admixed with nevus cells are Slug-negative. A similar
pattern of staining was seen in three of four melanomas containing residual
nevus cells.expression or localization in human melanocytic tumors.MITF, the master regulator of melanogenesis, has
been reported both to transcriptionally regulate Slug ex-
pression and to be a potential target of Slug regulation.14
In the present study, MITF protein was expressed in 11%
to 20% of tumors on the commercial array, with expres-
sion highest in acral melanomas and lowest in metastatic
melanomas; differences, however were not statistically
significant. There was no significant relationship between
Slug and MITF protein expression. MITF positivity was
higher in the custom array, ranging from 21% of meta-
static melanomas to 58% of primary melanomas to 77%
of nevi (Figure 1B), and differences between expression
in nevi versus metastatic melanomas (P  0.0001) and
primary melanomas versus metastatic melanomas (P 
0.0001) were significant. MITF expression paralleled Slug
expression (Figure 1B), and there was a significant pos-
itive association between Slug and MITF protein in nevi
(P  0.0239) and primary melanomas (P  0.0038).
Slug Expression in Melanocytes and Melanoma
Cells
The finding that Slug protein expression was actually
higher in nevi than melanomas was somewhat unex-
pected, although few nevi have been previously exam-
ined for Slug expression.46 This suggested that Slug
might play its most important role early in melanoma
progression (ie, in the emergence of nevi rather than in
the acquisition of invasive and metastatic characteris-
tics). Thus, Slug expression was compared in NHM of
neonatal origin and primary (WM115) and metastatic
(WC62) human melanoma cell lines. Primary and meta-
static cell lines were originally obtained from the same
patient (Coriell, Camden, NJ). All studies were performed
in confluent cells, as cell density dramatically influences
basal Slug expression in some cell lines,34,47 and expres-
sion was compared by RT-qPCR (Figure 3A) and West-
ern blot (Figure 3B). Endogenous Slug mRNA and protein
expression was highest in NHM and lowest in metastatic
melanoma cells. In contrast, Snail expression was higher
in both melanoma cell lines as compared to NHM. Snail
mRNA expression was higher in metastatic compared to
primary melanomas, whereas Snail protein levels were
higher in primary than in metastatic melanomas. This
observation underscored the fact that mRNA levels of
Snail and Slug might not have accurately reflected their
protein levels. Differences in Slug and Snail mRNA ex-
pression were statistically significant (P  0.01) for NHM
compared to both primary and metastatic melanoma
cells (Figure 3B). Thus, mRNA and protein expression of
these two highly related Snail family genes was inversely
related, an unexpected finding based on previous re-
ports of increased Snail expression in melanomas and
the fact that Slug and Snail are believed to have overlap-
ping functions.21,24,26,28
In NHM expressing high levels of endogenous Slug,
E-cadherin mRNA, and protein expression were also
high, whereas E-cadherin mRNA was undetectable in
melanoma cell lines (WM115 and WC62) that expressed
low levels of Slug (Figures 3, A and B). The high levels of
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melanoma cell lines was somewhat unexpected, given
that the analysis of custom melanoma array indicated an
increase in E-cadherin expression during melanoma pro-
gression. The two datasets, however, were not strictly
comparable. E-cadherin expression was not evaluated
immunohistochemically in normal human melanocytes in
tissue sections, nor were nevus cell lines compared with
NHM and melanoma cell lines. Taken together, however,
tissue immunohistochemistry and cell culture results
highlighted the fact that there was no simple relationship
between Slug and E-cadherin protein expression.
N-cadherin mRNA and protein were expressed at very
low levels in NHM, but at significantly (P  0.01) higher
levels in both melanoma cell lines. A shift from E-cadherin
Figure 3. Endogenous Slug expression is higher at both mRNA and protein
levels in NHM than in primary (WM115) or metastatic (WC62) melanoma cell
lines. A: RT-qPCR revealed significantly higher expression of Slug and E-
cadherin mRNAs in NHM than in primary or metastatic melanoma cells,
whereas Snail and N-cadherin expression were significantly lower. Error bars
indicate SDs. *P  0.01 compared to both primary and metastatic melanoma
cells. B: Western blots confirmed that differences in mRNA levels were
reflected in differences in protein expression in NHM versus primary and
metastatic melanoma cell lines. Both mRNA and protein were extracted from
confluent cell cultures to eliminate density-dependent variations in expres-
sion of Slug and its putative target genes. MITF isoforms include both
melanocyte-specific (M) and ubiquitous (A) isoforms.to N-cadherin expression is a well-known feature of mel-anoma progression,43 but our findings suggested that
this shift was not related to increased Slug expression.
P-cadherin and vimentin protein expression was higher in
metastatic melanoma cells than in normal melanocytes,
as previously reported.26,48,49 Multiple isoforms of MITF,
however, were observed on Western blots; there was
higher expression of the melanocyte-specific isoform of
MITF in NHM compared to melanoma cells (Figure 3B).
Effects of Exogenous Slug on Melanocytes and
Melanoma Cells
NHM and metastatic melanoma cells were infected with
adenoviral vectors inducing high levels of exogenous
Slug (Ad-Slug) to determine whether Slug had differential
effects on the two cell types. Expression levels were
determined 72 hours after transduction by Western blot
(Figure 4, A and B). High levels of Slug protein expres-
sion were obtained in both NHM and metastatic mela-
noma cells (WC62). Expression of exogenous Slug sig-
nificantly (P  0.0001) reduced expression of E-cadherin
mRNA in NHM, but had no effect on E-cadherin expres-
sion in melanoma cells, which did not express detectable
E-cadherin mRNA either before or after Slug transduc-
tion. Moreover, Slug overexpression caused a dramatic
internalization of E-cadherin protein in NHM (Figure 5).
Levels of N-cadherin mRNA and protein expression were
low in both NHM and melanoma cells, but Slug signifi-
cantly (P  0.01) increased N-cadherin mRNA expres-
sion in both cell types. The effect of Slug on cadherin
expression in the two cell lines, although modest, was
consistent with previous reports.5,41,46,50 Enhanced Slug
expression appeared to have little effect on vimentin pro-
tein expression in either cell type (Figure 4B).
MITF is a recognized marker of melanocyte lineage.
MITF expression promotes melanoma cell survival and
stimulates melanoma cell migration.51,52 In NHM express-
ing high levels of exogenous Slug, there was an increase in
expression of the M isoform of MITF, the isoform reported to
be relatively melanocyte-specific;53 however, expression of
exogenous Slug in melanoma cells did not enhance pro-
duction of the MITF M isoform. Slug overexpression did
not alter Snail expression in either cell type (Figure 4B),
suggesting that Slug did not directly regulate Snail ex-
pression.
There were no differences in proliferation in Slug-over-
expressing cells compared to control cells as determined
by MTT and standard cell counting methods, and neither
Slug-transduced NHM nor melanoma cells acquired the
ability to grow in soft agar (data not shown). Slug sub-
stantially enhanced cell migration in both NHM and met-
astatic melanoma (WC62) cells, as measured by migra-
tion to cover a cell layer defect (Figure 6A), and
significantly (P  0.05) enhanced their migration through
an uncoated Boyden chamber (Figure 6B). Slug also
enhanced melanoma cell invasiveness, as indicated by
significantly (P  0.05) increased migration through a
Matrigel-coated Boyden chamber (Figure 6C); however,
Slug had little effect on NHM invasiveness. The pro-
nounced effect of Slug overexpression on cell migration
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Slug on E-cadherin expression. Slug overexpression only
modestly reduced total E-cadherin protein expression in
NHM; however, Slug overexpression did cause E-cad-
herin protein to be relocalized from the melanocyte cell
membrane to the cytoplasm, which might have ac-
counted for the effect of Slug on the motility of these cells.
Melanoma cells, in contrast, expressed miniscule
amounts of E-cadherin, either with or without Slug over-
expression, yet Slug overexpression significantly en-
hanced their motility. In addition, while increased expres-
sion of melanocyte-specific MITF might have contributed
to the enhanced motility of Slug-overexpressing melano-
cytes, a similar increase in MITF expression was not seen
in Slug-overexpressing melanoma cells with increased
motility.
Discussion
The role of Slug in driving EMT during melanocyte differen-
tiation suggests that Slug may also play an important role in
melanoma progression by enhancing motility and invasive-
ness. Thus Slug expression would be expected to in-
crease as melanomas become more invasive and meta-
static. RNA microarray studies of melanomas and
melanoma cell lines have generally compared Slug ex-
pression in melanomas to expression of internal stan-
dards or to Slug expression in normal skin. In melanoma
cell lines, Slug expression has been reported to be in-
creased by 8- to 156-fold, depending on the cell lines
and standards used.54–56 These reports should be inter-
preted with caution, however, as our previous studies of
Slug expression in keratinocytes have shown that Slug
expression is highly dependent on cell density.34 Exam-ining Slug expression in nonconfluent melanoma cell
lines may thus provide artificially high estimates of basal
Slug expression. RNA microarray studies using tumor
samples suggest a somewhat lower level of Slug expres-
sion in nevi and melanomas, with Slug mRNA expression
being elevated only 2.8- to 3.3-fold in nevi and 2- to
4.5-fold in melanomas compared to normal skin.57,58 In-
deed, one study failed to detect any difference between
Slug mRNA expression in skin versus melanomas.59 It is
important to note that Slug is expressed in the basal
keratinocytes of normal epidermis,60 thus normal skin
may not be the best choice as a standard for comparison.
In addition, a significant limitation of all RNA microarray
studies is that Slug mRNA levels in cell lines or in tumors
may not correlate well with Slug protein levels, as protein
levels are modulated post-translationally.61
In contrast to expectations, our immunohistochemistry
studies examining a large number of melanocytic tumors
in a custom array clearly showed that Slug protein ex-
pression was significantly higher in nevi and primary mel-
Figure 5. Slug-expressing adenovirus (Ad-Slug) causes relocalization of E-
cadherin protein from the cell membrane of NHM. NHM transduced with a
control adenovirus (Ad-null) expressed abundant E-cadherin on the cell
Figure 4. NHM and melanoma cells transduced
with Slug-expressing adenovirus (Ad-Slug) express
less E-cadherin and more N-cadherin mRNA and
protein than cells transduced with a control adeno-
virus (Ad-null). A: RT-qPCR revealed significantly
lower E-cadherin expression in NHM transduced
with Ad-Slug compared to Ad-Null-transduced cells.
Neither Ad-Slug nor Ad-Null-transfected WC62 cells
expressed detectable E-cadherin mRNA. N-cadherin
levels were significantly increased in Ad-Slug-trans-
duced NHM and melanoma cells compared to Ad-
Null-transduced cells, although basal levels of ex-
pression were low and increases were modest. Note
the difference in scale for the two graphs. Error bars
indicate SEMs. *P  0.03. B: Western blot results
confirmed that Ad-Slug enhanced Slug protein ex-
pression in NHM and melanoma cells and that the
differences seen in mRNA levels for E-cadherin in
NHM and N-cadherin in melanoma cells were re-
flected in differences in protein expression. In addi-
tion, Ad-Slug transduction also enhanced expression
of melanocyte-specific MITF (M) in NHM but not in
melanoma cells. Melanoma cells expressed higher
levels of the MITF isoform constitutively expressed
in many tissues (A) and expression of this isoform
was not altered by Ad-Slug transduction. Ad-Slug
transduction did not alter levels of Snail expression
in either cell type.surface, whereas Ad-Slug-transduced NHM exhibited little or no membrane
localization of E-cadherin.
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higher in nevi than in primary melanomas (P  0.0534).
Moreover, our in vitro studies revealed that confluent NHM
expressed higher levels of Slug mRNA and protein than
cells derived from primary or metastatic melanomas.
Taken together, these findings suggest a role for Slug
early during melanoma development, rather than dur-
Figure 6. Slug-expressing adenovirus (Ad-Slug) enhances migration and
invasion in NHM and melanoma cells (WC62). A: NHM and melanoma cells
expressing exogenous Slug (Ad-Slug) migrated more rapidly to cover a defect
in the confluent cell layer than cells expressing a control adenovirus (Ad-
Null). Cultures were photographed 3 days after the introduction of the defect.
B: Ad-Slug-transduced NHM and melanoma cells had significantly enhanced
motility compared to Ad-Null-transduced cells. Migration of cells through an
uncoated membrane measured motility. Cells were transduced with Ad-Slug
or Ad-Null; after 72 hours, cells were placed in the upper portion of the cell
culture chamber and allowed to migrate for 24 hours. Cell migration was
quantified by removing cells from the upper surface of the membrane,
staining cells on the lower surface of the membrane, extracting the retained
dye, and determining the absorbance of the extract. Migration of cells
through an uncoated membrane measured motility. C: Ad-Slug significantly
enhanced the invasiveness of melanoma cells, but not NHM. Migration of
cells through a Matrigel-coated membrane measured invasiveness. Error bars
indicate SDs. *P  0.05.ing later stages of melanoma invasion and metastasis.This conclusion is consistent with the findings of
Koefinger et al,46 who reported higher expression of
Slug protein in nevi than in primary or metastatic mel-
anomas. However, these investigators also reported that
cytoplasmic Slug staining was stronger in primary melano-
mas and metastases than in nevi, whereas we have never
observed cytoplasmic Slug immunoreactivity. Cytoplasmic
staining observed in previous studies is likely to be artifac-
tual, as the lack of specificity of many antibodies raised
against Slug is well known.20,34
Although a role for Slug in melanoma metastasis has
been postulated, we show here and a number of RNA
microarray studies have shown that Slug is not a pre-
dictor of melanoma metastasis.58,59,62–64 Critical
changes in expression of a variety of oncogenes and
tumor suppressor genes may take place relatively early
during melanoma progression;59,64,65 perhaps Slug
expression is similarly required only early in mela-
nomagenesis. An early role for Slug is consistent with
the inverse relationship between Slug and Snail ex-
pression we observed in NHM and melanoma cells. In
this regard, it has been suggested that Slug expression
precedes Snail expression during breast cancer devel-
opment and that Slug sets the stage for Snail-mediated
tumor progression.36 In melanomas, Slug, but not Snail
or Twist cooperates with ZEB1 to repress E-cadherin
expression, indicating differential, perhaps sequential
expression of EMT drivers.50
E-cadherin is the canonical target of Slug and Snail
modulation during EMT.6,35,41 Slug and Snail bind to
E-boxes in the E-cadherin (Cdh1) promoter to sup-
press its expression.5,50 Studies in a variety of cell
types, including melanoma cell lines, have demon-
strated that expression of exogenous Slug enhances
motility and reduces the expression of adherens junc-
tions.7 On the other hand, knocking down Slug expres-
sion renders cells resistant to growth factor-induced
EMT and inhibits the switch from E- to N-cadherin
characteristic of EMT.44,46 In our in vitro studies, exog-
enous Slug expression enhanced motility in NHM and
melanoma cells, increased invasiveness in melanoma
cells, suppressed E-cadherin expression in NHM, and
enhanced N-cadherin expression in NHM and mela-
noma cells. Overall, these effects were consistent with
previous reports.5,41,46,50
A number of immunohistochemical studies of human
tumors have shown the expected inverse relationship
between Slug and E-cadherin expression.6,11,35–41 In
the present study, however, we were unable to validate
a relationship between Slug and E-cadherin protein
expression by immunohistochemistry in tumor microar-
rays. Other studies have also failed to demonstrate an
association between Slug and E-cadherin expression
in tumors.66–70 Thus, the relationship between Slug
and E-cadherin expression in tumors remains some-
what unclear, and studies in cell lines may not accu-
rately predict findings in primary tumors. Previous im-
munohistochemical studies performed with poorly
characterized antibodies and without careful assess-
ment of nuclear versus cytoplasmic staining may not
be reliable.20 For the present studies, we used a vali-
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only in nuclei.34
We did not see a clear relationship between expres-
sion of Slug and its target gene E-cadherin (Cdh1),
although we did find an association between expres-
sion of MITF and Slug. MITF binds to and activates the
Slug promoter in vitro.14 Interestingly, overexpression
of Slug in Xenopus embryos dramatically increases
MITF expression, suggesting that Slug and MITF may
reciprocally regulate one another;17 however, Slug ex-
pression is not required for MITF expression, as MITF is
detected in Slug null cells.14 Multiple observations
support a role for Slug in melanogenesis. Slug deficient
mice display hypopigmentation at the extremities and
on the head and Slug mutations are found in the he-
reditary pigmentary defects Waardenberg syndrome
type II and piebaldism.14,71 The pathway by which Slug
regulates pigmentation is unknown, although MITF and
SCF/c-kit signaling pathways likely play critical roles.
Studies to date suggest that Slug plays a role in
melanomagenesis and that this role is related to the
function of Slug in EMT during development. Although
Slug appears to enhance melanocyte motility both in
emigrating neural crest cells and in normal melano-
cytes and melanoma cells, presumably by down-reg-
ulating E-cadherin expression, it remains to be seen
whether the two processes are strictly comparable.
Our studies highlight the fact that there is no simple
relationship between Slug and E-cadherin expression
either in cultured melanocytes and melanoma cells or
in primary human melanocytic tumors. Moreover, the
effect of Slug on melanocyte and melanoma cell motil-
ity is relatively independent of the effect of Slug on
E-cadherin expression or localization. Surprisingly,
Slug and Snail, two closely related genes, both of
which promote cell motility, appear to be differentially
regulated in melanocytes and melanoma cells.
The mechanisms by which Slug affects melanoma pro-
gression and the interactions of Slug with other EMT
drivers may have important implications for intervention in
melanoma progression. Our studies suggest a role for
Slug early in the transformation of melanocytes to mela-
noma cells, although the timing, consequences, and im-
portance of Slug expression during melanoma progres-
sion remain unclear.
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